• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度肺癌流行病学的演变:减少非小细胞肺癌(未另行说明)并量化烟草烟雾暴露是关键。

Evolving epidemiology of lung cancer in India: Reducing non-small cell lung cancer-not otherwise specified and quantifying tobacco smoke exposure are the key.

作者信息

Kaur H, Sehgal I S, Bal A, Gupta N, Behera D, Das A, Singh N

机构信息

Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

Indian J Cancer. 2017 Jan-Mar;54(1):285-290. doi: 10.4103/ijc.IJC_597_16.

DOI:10.4103/ijc.IJC_597_16
PMID:29199707
Abstract

BACKGROUND

Adenocarcinoma is the most prevalent histological type of lung cancer (LC) in developed countries while squamous cell carcinoma (SqCC) has so far been the most common type at our center. Herein, we report our continued assessment of the epidemiological trend of LC aimed at determining any change in the histological distribution.

METHODS

Retrospective analysis involving all consecutive newly diagnosed LC patients over a 4-year period (March 2011-February 2015). Demographic characteristics, histology, and staging data for current data set were compared with our previously published data (2008-2011). As before, smoking index (SI) was used to group patients as never (SI = 0), light (SI = 1-100), moderate (SI = 101-300), and heavy (SI ≥301) smokers.

RESULTS

Majority of 1301 patients had advanced disease (Stages IIIB = 30.1%; IV = 53.3%), were males (82.3%) and current/ex-smokers (76.9%). Adenocarcinoma and SqCC (36.4% each) were equally prevalent. As compared to our previous study, adenocarcinoma increased (36.4% vs. 27.5%) and nonsmall cell lung cancer-not otherwise specified (NSCLC-NOS) decreased (5.1% vs. 10.9%) significantly (P < 0.001). The current study had more heavy smokers (68.3% vs. 61.1%; P = 0.013) and median SI was also higher (500 vs. 400; P = 0.001). Among SI-based groups, significant differences were observed for age, gender, body mass index, histology, TNM stage, and metastatic disease distribution.

CONCLUSION

Reduction in NSCLC-NOS has led to adenocarcinoma and SqCC being equally prevalent at our center in North India despite an increase in heavy smokers. Accurate histological NSCLC subtyping is necessary for optimal epidemiological assessment.

摘要

背景

在发达国家,腺癌是肺癌(LC)最常见的组织学类型,而在我们中心,鳞状细胞癌(SqCC)是迄今为止最常见的类型。在此,我们报告对肺癌流行病学趋势的持续评估,旨在确定组织学分布的任何变化。

方法

回顾性分析涉及4年期间(2011年3月至2015年2月)所有连续新诊断的肺癌患者。将当前数据集的人口统计学特征、组织学和分期数据与我们之前发表的数据(2008 - 2011年)进行比较。和以前一样,吸烟指数(SI)用于将患者分为从不吸烟(SI = 0)、轻度吸烟(SI = 1 - 100)、中度吸烟(SI = 101 - 300)和重度吸烟(SI≥301)者。

结果

1301例患者中大多数患有晚期疾病(IIIB期 = 30.1%;IV期 = 53.3%),为男性(82.3%)且为现吸烟者/既往吸烟者(76.9%)。腺癌和SqCC(各占36.4%)同样常见。与我们之前的研究相比,腺癌增加(36.4%对27.5%),非小细胞肺癌-未另行特指(NSCLC-NOS)显著减少(5.1%对10.9%)(P < 0.001)。当前研究中有更多重度吸烟者(68.3%对61.1%;P = 0.013),且吸烟指数中位数也更高(500对400;P = 0.001)。在基于吸烟指数的分组中,观察到年龄、性别、体重指数、组织学、TNM分期和转移疾病分布存在显著差异。

结论

尽管重度吸烟者增加,但NSCLC-NOS的减少导致在印度北部我们中心腺癌和SqCC同样常见。准确的非小细胞肺癌组织学亚型分类对于最佳的流行病学评估是必要的。

相似文献

1
Evolving epidemiology of lung cancer in India: Reducing non-small cell lung cancer-not otherwise specified and quantifying tobacco smoke exposure are the key.印度肺癌流行病学的演变:减少非小细胞肺癌(未另行说明)并量化烟草烟雾暴露是关键。
Indian J Cancer. 2017 Jan-Mar;54(1):285-290. doi: 10.4103/ijc.IJC_597_16.
2
Lung cancer in never-smokers - what are the differences?从不吸烟者的肺癌——有哪些差异?
Acta Oncol. 2017 Jul;56(7):931-935. doi: 10.1080/0284186X.2017.1287944. Epub 2017 Feb 17.
3
Clinico-pathology of lung cancer in a regional cancer center in Northeastern India.印度东北部某地区癌症中心肺癌的临床病理学
Asian Pac J Cancer Prev. 2013;14(12):7277-81. doi: 10.7314/apjcp.2013.14.12.7277.
4
Epidemiological changes in the histological subtypes of 35,018 non-small-cell lung cancer cases in Brazil.巴西35018例非小细胞肺癌病例组织学亚型的流行病学变化
Lung Cancer. 2016 Jul;97:66-72. doi: 10.1016/j.lungcan.2016.04.019. Epub 2016 Apr 29.
5
The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.非小细胞肺癌中吸烟量的预后影响——腺癌与鳞状细胞癌之间的差异
Lung Cancer. 2014 Aug;85(2):125-30. doi: 10.1016/j.lungcan.2014.06.006. Epub 2014 Jun 16.
6
Epidemiology of lung cancer in India: focus on the differences between non-smokers and smokers: a single-centre experience.印度肺癌的流行病学:关注非吸烟者与吸烟者之间的差异:单中心经验
Indian J Cancer. 2012 Jan-Mar;49(1):74-81. doi: 10.4103/0019-509X.98925.
7
Metastatic nonsmall cell lung cancer in South India: A regional demographic study.
Indian J Cancer. 2017 Jan-Mar;54(1):267-270. doi: 10.4103/0019-509X.219566.
8
Temporal changes in lung cancer: a 10-year study in a chest hospital.肺癌的时间变化:在一家胸科医院进行的为期10年的研究。
Monaldi Arch Chest Dis. 2008 Dec;69(4):157-63. doi: 10.4081/monaldi.2008.377.
9
The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.国际肺癌研究协会分期项目:手术治疗的非小细胞肺癌的预后因素及病理TNM分期
J Thorac Oncol. 2009 Jul;4(7):792-801. doi: 10.1097/JTO.0b013e3181a7716e.
10
Lung cancer histopathology in the Thrace region of Turkey and comparison with national data.土耳其色雷斯地区的肺癌组织病理学及其与全国数据的比较。
Tuberk Toraks. 2005;53(2):132-8.

引用本文的文献

1
Clinical characteristics and first-line palliative treatment patterns in 3,414 patients with advanced lung cancer in India.印度3414例晚期肺癌患者的临床特征及一线姑息治疗模式
Ecancermedicalscience. 2025 Mar 6;19:1867. doi: 10.3332/ecancer.2025.1867. eCollection 2025.
2
Spectrum of Thoracic Diseases (Benign and Malignant) in North Western India: A Study of 2527 Cases.印度西北部胸科疾病谱(良性和恶性):2527例病例研究
Indian J Surg Oncol. 2025 Apr;16(2):660-666. doi: 10.1007/s13193-024-02124-4. Epub 2024 Oct 30.
3
Carcinoma lung with cutaneous metastasis: experience from an Indian institute.
伴有皮肤转移的肺癌:来自一家印度机构的经验
Rep Pract Oncol Radiother. 2025 Feb 19;29(6):690-699. doi: 10.5603/rpor.103526. eCollection 2024.
4
Lung cancer in Asia: the impact of climate change.亚洲的肺癌:气候变化的影响
EClinicalMedicine. 2024 Jul 8;74:102680. doi: 10.1016/j.eclinm.2024.102680. eCollection 2024 Aug.
5
Uniqueness of lung cancer in Southeast Asia.东南亚肺癌的独特性。
Lancet Reg Health Southeast Asia. 2024 Jul 8;27:100430. doi: 10.1016/j.lansea.2024.100430. eCollection 2024 Aug.
6
Chemotherapy related changes in cfDNA levels in squamous non-small cell lung cancer: correlation with symptom scores and radiological responses.鳞状非小细胞肺癌中化疗相关的循环游离DNA水平变化:与症状评分及影像学反应的相关性
Explor Target Antitumor Ther. 2024;5(3):508-521. doi: 10.37349/etat.2024.00232. Epub 2024 May 28.
7
Demographic and clinical characteristics of primary lung cancer patients in Kerala: Analysis of data from six teaching centers.喀拉拉邦原发性肺癌患者的人口统计学和临床特征:来自六个教学中心的数据分析。
J Family Med Prim Care. 2023 Oct;12(10):2501-2506. doi: 10.4103/jfmpc.jfmpc_2176_22. Epub 2023 Oct 9.
8
The global burden of lung cancer: current status and future trends.全球肺癌负担:现状与未来趋势。
Nat Rev Clin Oncol. 2023 Sep;20(9):624-639. doi: 10.1038/s41571-023-00798-3. Epub 2023 Jul 21.
9
Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer.伴有外显子 19 缺失和外显子 21 L858R EGFR 突变的肺腺癌非小细胞肺癌患者的临床病理特征、治疗和结局的差异。
BMJ Open Respir Res. 2023 Jun;10(1). doi: 10.1136/bmjresp-2022-001492.
10
Navigating patient journey in early diagnosis of lung cancer in India.在印度肺癌早期诊断中引导患者就医过程。
Lung India. 2023 Jan-Feb;40(1):48-58. doi: 10.4103/lungindia.lungindia_144_22.